Jessica Sachs
Chief Medical Officer · Cogent Biosciences, Inc.
- 2025
- Dec 30, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jessica Sachs files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $370.02M in COGT purchases and sales in the last 12 months
- John Edward Robinson - $3.49M in COGT purchases and sales in the last 12 months
- John L. Green - $2.98M in COGT purchases and sales in the last 12 months
- Evan Kearns - $2.52M in COGT purchases and sales in the last 12 months
- Arlene Morris - $1.69M in COGT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jessica Sachs?
Jessica Sachs is a corporate insider, tracked as Chief Medical Officer of Cogent Biosciences, Inc. (COGT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jessica Sachs last file a Form 4?
The most recent primary Form 4 on record is dated 30 December 2025, one of 2 filings going back to 2025.
Has Jessica Sachs been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($3.20M) across all tracked filings.
